Loading: 100%
TESARO, Inc. logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees 446 (as per Q1 2017)no data available
Sector Biotechnology, HealthcareBiotechnology, Healthcareno data available
Ticker TSROno data available
Financial year endsFY ends End of Decemberno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 17100125150175200
datesClosing price (adj.)
13.10.2017123.00
11.10.2017117.91
04.10.2017121.82
27.09.2017120.10
20.09.2017121.62
13.09.2017115.63
06.09.2017129.77
30.08.2017126.58
23.08.2017120.40
16.08.2017112.99
09.08.2017116.18
02.08.2017124.41
26.07.2017130.06
19.07.2017124.02
12.07.2017138.35
05.07.2017140.05
27.06.2017141.03
20.06.2017137.97
13.06.2017148.94
06.06.2017138.75
30.05.2017143.43
23.05.2017155.17
16.05.2017149.51
09.05.2017137.89
02.05.2017143.28
25.04.2017138.44
18.04.2017146.01
11.04.2017141.07
04.04.2017149.19
28.03.2017154.90
21.03.2017149.67
14.03.2017153.65
07.03.2017177.14
28.02.2017188.37
21.02.2017190.27
14.02.2017182.26
07.02.2017162.95
31.01.2017162.84
24.01.2017142.57
17.01.2017151.25
10.01.2017147.24
03.01.2017133.25
27.12.2016136.66
19.12.2016127.24
12.12.2016131.82
05.12.2016139.56
28.11.2016137.11
21.11.2016134.46
14.11.2016148.50
07.11.2016123.55
31.10.2016120.88
24.10.2016117.80
17.10.2016110.97
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
123.00n/a
Market Capitalisation
in million USD
6,625n/a
Enterprise Value
in million USD
6,088n/a
Common Shares Outstanding
as per May 3, 2017
53,864,741n/a
Preferred Shares Outstanding
as per May 3, 2017
n/a
Average Basic Shares Outstanding
TTM
50,831,750n/a
Average Diluted Shares Outstanding
TTM
n/a
Index Membership
n/a
Business Summary
Tesaro Inc is an oncology-focused biopharmaceutical company. It focuses on developing treatments for cancer.
no data available
Key Financials & Ratios (all figures TTM as per Mar 31, 2017, million USD, full statements further below)
Profit & Loss
Revenues 48n/a
Gross Profit 44n/a
Operating Income -402n/a
EBITDA 0n/a
Net Profit -433n/a
Balance Sheet
Cash and Cash Equivalents 672n/a
Receivables 6n/a
Total Current Assets 708n/a
PP&E 9n/a
Total Assets 761n/a
Accounts Payable 10n/a
Current Debt 0n/a
Total Current Liabilities 107n/a
Long-Term Debt 135n/a
Total Liabilities 248n/a
Total Equity 513n/a
Cash Flow
Depreciation & Amortisation 0n/a
Change in Working Capital 0n/a
Operating Cash Flow 0n/a
Net Change in PP&E and Intangibles 0n/a
Investing Cash Flow 0n/a
Dividends Paid 0n/a
Financing Cash Flow 0n/a
Total Change in Cash 0n/a
Free Cash Flow 0n/a
Profitability Ratios
Gross Margin 92.6%n/a
Operating Margin -844.9%n/a
Net Profit Margin -910.2%n/a
Return on Equity -84.4%n/a
Return on Assets -56.9%n/a
Per Share Figures
Basic EPS -8.52n/a
Diluted EPS n/a
Sales per Share 0.94n/a
Book Value per Share 10.10n/a
FCF per Share n/a
Dividends per Share n/a
Price Multiples
Price to Earnings Ratio -14.43n/a
Price to Sales Ratio 131.36n/a
Price to Book Value 12.18n/a
Price to Free Cash Flow n/a
Valuation Metrics
EV/EBITDA n/a
EV/Sales 127.90n/a
Book to Market Value 0.08n/a
Other Ratios
Current Ratio 658.4%n/a
Liabilities to Equity Ratio 48.3%n/a
Debt to Assets Ratio 17.7%n/a
Profit & Loss StatementP&L data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '11FY '12FY '13FY '14FY '15FY '16
Revenue
0
0
0
0
0
45
Sales & Services Revenue
0
0
0
0
0
0
Financing Revenue
0
0
0
0
0
0
Other Revenue
0
0
0
0
0
0
Cost of revenue
0
0
0
0
0
-3
Cost of Goods & Services
0
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
0
Gross Profit
0
0
0
0
0
42
Other Operating Income
0
0
0
0
0
0
Operating Expenses
-15
-54
-91
-142
-234
-394
Selling, General & Administrative
-3
-7
-15
-24
-79
-159
Selling & Marketing
0
0
0
0
0
0
General & Administrative
0
0
0
0
0
0
Research & Development
-12
-47
-76
-118
-155
-235
Depreciation & Amortization
0
0
0
0
0
0
Provision For Doubtful Accounts
0
0
0
0
0
0
Other Operating Expense
0
0
0
0
0
0
Operating Income (Loss)
-15
-54
-91
-142
-234
-352
Non-Operating Income (Loss)
-1
0
0
-4
-15
-15
Interest Expense, net
0
0
0
-4
-15
-15
Interest Expense
0
0
0
0
0
0
Interest Income
0
0
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
0
0
Other Non-Operating Income (Loss)
-1
0
0
0
0
0
Pretax Income (Loss), Adjusted
-16
-54
-90
-146
-249
-367
Abnormal Gains (Losses)
-1
-8
-2
-25
-2
-19
Acquired In-Process R&D
0
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
0
Sale of Business
0
0
0
0
0
0
Legal Settlement
0
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
0
Pretax Income (Loss)
-16
-62
-92
-171
-251
-386
Income Tax (Expense) Benefit, net
0
0
0
0
0
-1
Current Income Tax
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
0
Income (Loss) from Continuing Operations
-16
-62
-92
-171
-251
-387
Net Extraordinary Gains (Losses)
0
0
0
0
0
0
Discontinued Operations
0
0
0
0
0
0
XO & Accounting Charges & Other
0
0
0
0
0
0
Income (Loss) Including Minority Interest
-16
-62
-92
-171
-251
-387
Minority Interest
0
0
0
0
0
0
Net Income
-16
-62
-92
-171
-251
-387
Preferred Dividends
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
Net Income Available to Common Shareholders
-16
-62
-92
-171
-251
-387
Remarks
restated on Mar 14, 2014 n/a
calculated values,
restated on Feb 25, 2015 n/a
calculated values,
restated on Feb 29, 2016 n/a
calculated values,
restated on Feb 28, 2017 n/a
calculated values,
restated on Feb 28, 2017 n/a
calculated values,
restated on Feb 28, 2017 n/a
calculated values,
Balance SheetBS data quality: 98% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '11FY '12FY '13FY '14FY '15FY '16
Assets
Cash, Cash Equivalents & Short Term Investments
40
125
130
257
230
786
Cash & Cash Equivalents
40
125
130
257
230
786
Short Term Investments
0
0
0
0
0
0
Accounts & Notes Receivable
0
0
0
0
1
6
Accounts Receivable, Net
0
0
0
0
1
6
Notes Receivable, Net
0
0
0
0
0
0
Unbilled Revenues
0
0
0
0
0
0
Inventories
0
0
0
0
1
15
Raw Materials
0
0
0
0
0
0
Work In Process
0
0
0
0
0
0
Finished Goods
0
0
0
0
0
0
Other Inventory
0
0
0
0
0
0
Other Short Term Assets
3
1
4
2
5
11
Prepaid Expenses
0
0
0
0
0
0
Derivative & Hedging Assets
0
0
0
0
0
0
Assets Held-for-Sale
0
0
0
0
0
0
Deferred Tax Assets
0
0
0
0
0
0
Income Taxes Receivable
0
0
0
0
0
0
Discontinued Operations
0
0
0
0
0
0
Miscellaneous Short Term Assets
3
1
4
2
5
11
Total Current Assets
42
127
134
259
236
817
Property, Plant & Equipment, Net
0
0
0
1
3
7
Property, Plant & Equipment
0
0
0
0
0
0
Accumulated Depreciation
0
0
0
0
0
0
Long Term Investments & Receivables
0
0
0
0
0
0
Long Term Investments
0
0
0
0
0
0
Long Term Marketable Securities
0
0
0
0
0
0
Long Term Receivables
0
0
0
0
0
0
Other Long Term Assets
0
1
1
1
16
18
Intangible Assets
0
0
0
0
15
13
Goodwill
0
0
0
0
0
0
Other Intangible Assets
0
0
0
0
0
0
Prepaid Expense
0
0
0
0
0
0
Deferred Tax Assets
0
0
0
0
0
0
Derivative & Hedging Assets
0
0
0
0
0
0
Prepaid Pension Costs
0
0
0
0
0
0
Discontinued Operations
0
0
0
0
0
0
Investments in Affiliates
0
0
0
0
0
0
Miscellaneous Long Term Assets
0
1
1
1
1
5
Total Noncurrent Assets
0
1
1
2
19
25
Total Assets
43
127
136
260
255
842
Liabilities and owners' equity
Payables & Accruals
4 3585000
12 11715000
12 12410000
23 22839000
45 44647000
74 73936000
Accounts Payable
1 605000
3 3170000
2 1869000
6 6089000
8 8019000
5 5236000
Accrued Taxes
0 0
0 0
0 0
0 0
0 0
0 0
Interest & Dividends Payable
0 0
0 0
0 0
0 0
0 0
0 0
Other Payables & Accruals
3 2980000
9 8545000
11 10541000
17 16750000
37 36628000
69 68700000
Short Term Debt
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Borrowings
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Capital Leases
0 0
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
0 0
0 0
0 0
0 0
0 0
0 0
Other Short Term Liabilities
0 11000
0 3000
0 13000
2 1526000
2 2034000
3 3073000
Deferred Revenue
0 0
0 0
0 0
0 0
1 500000
0 95000
Derivatives & Hedging
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
0 11000
0 3000
0 13000
2 1526000
2 1534000
3 2978000
Total Current Liabilities
4 3596000
12 11718000
12 12423000
24 24365000
47 46681000
77 77009000
Long Term Debt
0 0
0 0
0 0
112 111964000
121 121325000
132 131775000
Long Term Borrowings
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
0 0
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
0 3000
0 0
0 3000
0 0
0 401000
5 5391000
Accrued Liabilities
0 0
0 0
0 0
0 0
0 0
0 0
Pension Liabilities
0 0
0 0
0 0
0 0
0 0
0 0
Pensions
0 0
0 0
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Compensation
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
0 0
0 0
0 0
0 0
0 288000
0 305000
Deferred Tax Liabilities
0 0
0 0
0 0
0 0
0 0
0 0
Derivatives & Hedging
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
0 3000
0 0
0 3000
0 0
0 113000
5 5086000
Total Noncurrent Liabilities
0 3000
0 0
0 3000
112 111964000
122 121726000
137 137166000
Total Liabilities
4 3599000
12 11718000
12 12426000
136 136329000
168 168407000
214 214175000
Preferred Equity
64 64348000
0 0
0 0
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
0 305000
203 202798000
303 302650000
475 474566000
689 688792000
1,605 1604803000
Common Stock
0 0
0 0
0 0
0 0
0 0
0 0
Additional Paid in Capital
0 0
0 0
0 0
0 0
0 0
0 0
Other Share Capital
0 0
0 0
0 0
0 0
0 0
0 0
Treasury Stock
0 0
0 0
0 0
0 0
0 0
0 0
Retained Earnings
-25 -25373000
-87 -87136000
-179 -179498000
-351 -350510000
-602 -601918000
-974 -973761000
Other Equity
0 0
0 0
0 0
0 0
0 0
-3 -2924000
Equity Before Minority Interest
39 39280000
116 115662000
123 123152000
124 124056000
87 86874000
628 628118000
Minority Interest
0 0
0 0
0 0
0 0
0 0
0 0
Total Equity
39 39280000
116 115662000
123 123152000
124 124056000
87 86874000
628 628118000
Total Liabilities & Equity
43 42879000
127 127380000
136 135578000
260 260385000
255 255281000
842 842293000
Remarks restated on Feb 20, 2013 n/a restated on Mar 14, 2014 n/a restated on Feb 25, 2015 n/a restated on Feb 29, 2016 n/a restated on Feb 28, 2017 n/a restated on May 9, 2017 n/a
Cash Flow StatementCF data quality: 92% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '11FY '12FY '13FY '14FY '15FY '16
Net Income/Starting Line
-16
-62
-92
-171
-251
-387
Net Income
0
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
Depreciation & Amortization
0
0
0
0
1
3
Non-Cash Items
1
10
10
39
37
78
Stock-Based Compensation
0
0
0
0
0
0
Deferred Income Taxes
0
0
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
0
0
Change in Working Capital
1
9
-2
14
19
19
(Increase) Decrease in Accounts Receivable
0
0
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
0
0
0
Cash from Operating Activities
-14
-43
-85
-117
-195
-288
Change in Fixed Assets & Intangibles
-1
-8
-2
-26
-19
-22
Disposition of Fixed Assets & Intangibles
0
0
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
0
0
Net Change in Long Term Investment
0
0
0
0
0
0
Decrease in Long Term Investment
0
0
0
0
0
0
Increase in Long Term Investment
0
0
0
0
0
0
Net Cash From Acquisitions & Divestitures
0
0
0
0
0
0
Net Cash from Divestitures
0
0
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
0
0
Other Investing Activities
0
0
0
0
-1
-1
Net Cash From Discontinued Operations (investing)
0
0
0
0
0
0
Cash from Investing Activities
-1
-8
-2
-26
-20
-23
Dividends Paid
0
0
0
0
0
0
Cash From (Repayment of) Debt
0
0
0
195
0
0
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
0
0
Cash From Long Term Debt
0
0
0
0
0
0
Cash From (Repurchase of) Equity
52
136
92
96
188
867
Increase in Capital Stock
52
136
92
96
188
867
Decrease in Capital Stock
0
0
0
0
0
0
Other Financing Activities
0
0
0
-21
0
0
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
0
Cash from Financing Activities
52
136
92
270
188
867
Net Cash Before Disc. Operations and FX
37
85
5
127
-27
556
Change in Cash from Disc. Operations and Other
0
0
0
0
0
0
Net Cash Before FX
37
85
5
127
-27
556
Effect of Foreign Exchange Rates
0
0
0
0
0
0
Net Changes in Cash
37
85
5
127
-27
556
Remarks
restated on Mar 14, 2014 n/a
calculated values,
restated on Feb 25, 2015 n/a
calculated values,
restated on Feb 29, 2016 n/a
calculated values,
restated on Feb 28, 2017 n/a
calculated values,
restated on Feb 28, 2017 n/a
calculated values,
restated on Feb 28, 2017 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo